Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment

Esther S C Korf1, Lars-Olof Wahlund, Pieter Jelle Visser

  • 1Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands. e.pelgrim@vumc.nl

Neurology
|July 14, 2004
PubMed
Abstract

Insights

Visual assessment of medial temporal lobe atrophy (MTA) on MRI reliably predicts dementia in mild cognitive impairment (MCI) patients. This accessible method offers powerful insights into dementia progression.

Area of Science:

  • Neurology
  • Radiology
  • Geriatrics

Background:

  • Medial temporal lobe atrophy (MTA) assessment via volumetric MRI predicts dementia in mild cognitive impairment (MCI).
  • Volumetric MRI is not practical for routine clinical use.
  • A simpler method for MTA assessment is needed.

Purpose of the Study:

  • To evaluate the predictive accuracy of visually assessed MTA in MCI patients.
  • To utilize a standardized visual rating scale for MTA evaluation.

Main Methods:

  • Seventy-five MCI patients (mean age 63) underwent brain MRI.
  • Coronal 3D magnetization-prepared rapid gradient echo sequence was used.
  • MTA was rated visually using a 5-point scale.

Main Results:

  • 49% of MCI patients developed dementia within a 34-month follow-up.
  • Visually assessed MTA significantly predicted dementia (HR 1.5 per point increase, p < 0.001).
  • Predictive accuracy was independent of various clinical and demographic factors.

Conclusions:

  • Standardized visual MTA assessment on MRI is a strong, independent predictor of dementia conversion in younger MCI patients.
  • This method is valuable for routine clinical practice.
  • Individual patient odds should be considered due to score overlap.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...